Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2019-08-05 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2019
Transaction in Own Shares Classification · 100% confidence The document text is titled "Transaktioner i forbindelse med Novozymes' aktietilbagekøbsprogram" (Transactions related to Novozymes' share buyback program) and details the number of shares bought back on specific dates (July 29 to August 2, 2019) as part of a larger program announced in 2019. It explicitly mentions compliance with the Market Abuse Regulation (Markedsmisbrugsforordningen). This content directly relates to the company repurchasing or dealing in its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a detailed report/announcement of these transactions, not just a notice that a report is available (which would suggest RPA or RNS).
2019-08-05 English
Transaction in Own Shares 2019
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (401 characters) and explicitly states, "Please read the full announcement in the attached PDF" and provides a link to a document titled "Transactions under Novozymes’ stock buyback program". This indicates the document itself is merely an announcement about the availability of the full report, not the report content. A stock buyback program falls under the category of the company buying back or selling its own shares. Therefore, the most appropriate classification is Transaction in Own Shares (POS), but because this document is just an announcement pointing to the full details, it fits the 'MENU VS MEAL' rule, suggesting RPA or RNS. However, since POS is a specific category for share repurchase, and this announcement directly relates to that activity, it is more specific than a general RPA. Given the strong link to share transactions, I will classify it as POS, acknowledging the announcement nature, but POS is the subject matter.
2019-07-29 English
Transaction in Own Shares 2019
Transaction in Own Shares Classification · 100% confidence The document explicitly details transactions made under a 'stock buyback program' for Novozymes, reporting the number of shares purchased, average price, and total transaction value over several days (July 22 to July 26, 2019). This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The document is a detailed report of these transactions, not merely an announcement of a report's publication. Therefore, the appropriate code is POS.
2019-07-29 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a 'Selskabsmeddelelse' (Company Announcement) from Novozymes detailing the specific transactions of their share buyback program over a one-week period. It includes a summary table of daily transactions and a detailed appendix of every individual trade executed by Nordea. This falls under the category of 'Transaction in Own Shares' (POS), as it reports the company's buyback activity in compliance with market abuse regulations.
2019-07-29 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 95% confidence The document is a short announcement (427 characters) regarding transactions related to a share buyback program ('aktietilbagekøbsprogram'). It directs the reader to an attached file for the full details. According to the 'Menu vs Meal' rule, since this is a short announcement of a transaction in own shares rather than the full report itself, it is classified as a Transaction in Own Shares (POS).
2019-07-29 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from Novozymes regarding its share buyback program. It details the number of shares purchased, the transaction values, and provides a comprehensive appendix of individual trade data. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of companies buying back their own shares.
2019-07-22 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.